Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or EFV-based regimens for treatment of HIV-1 infection: a meta-analysis of randomized controlled trials

Overview of attention for article published in AIDS Research and Therapy, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,170 followers.

Dolutegravir combined with other ARTs is superior to RAL- or EFV- regimens for treatment of HIV-1 https://t.co/YgSlNAroT0 #AIDSResTherapy

Dolutegravir(DTG, S/GSK1349572) combined with other ARTs is superior to RAL- or… https://t.co/ZGlQcySmDF #AidsResTher

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.